First royalties from TEMCELL have probably been received as it went on sale in Feb16, but will not be significant as it has only been a month since sales started.
Once MSB gets its first product approved by the FDA, that will signal all fund managers to jump on board - no questions asked!
One thing we need to realise is that MSB does not have the cash to fund it to US Approval of MSC-100-IV or any other product it has in the pipe-line. With approval expected in late 2017, MSB will need a capital injection or more likely a strategic investment from one of the existing or new partners. The higher the share price when that is required, the less dilutive it will be ... so a higher share price is better for those who already have their skin in the game!
However in the short term I don't mind it being held down, just gives us all more buying opportunities ... the SP will fluctuate and we may be on small unrealised gains or losses... but it will be insignificant once the train leaves the station!
Good luck
To those holding this down, page-4
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.40 |
Change
0.045(3.33%) |
Mkt cap ! $1.592B | |||
| Open | High | Low | Value | Volume |
| $1.35 | $1.42 | $1.33 | $3.802M | 2.753M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 23940 | $1.39 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.40 | 22571 | 2 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |